The global allergy immunotherapy market size attained a value of USD 2 billion in 2022. The market is anticipated to grow at a CAGR of 9.6% during the forecast period of 2023-2031 to attain a value of USD 4.67 billion by 2031.
Allergy immunotherapy is used to treat a wide range of allergies, including seasonal allergies, food allergies, and allergies to pet dander, dust mites, and insect venom. It is typically recommended for individuals who have moderate to severe allergy symptoms that are not effectively controlled with medications or avoidance of the allergen.
The benefits of allergy immunotherapy include long-term relief from allergy symptoms, a reduced need for allergy medications, and the potential to prevent the development of asthma in children with allergies.
Allergy immunotherapy is typically administered in the form of injections, sublingual drops or tablets, or oral immunotherapy. Immunotherapy injections involve injecting small amounts of the allergen under the skin, while sublingual drops or tablets are placed under the tongue. Oral immunotherapy involves ingesting small amounts of the allergen in gradually increasing doses.
Allergy immunotherapy is typically administered by an allergist or immunologist in a clinical setting. Patients undergoing immunotherapy require close monitoring for potential side effects, such as allergic reactions.
In summary, allergy immunotherapy is a type of treatment that is used to reduce the symptoms associated with allergies. It involves gradually exposing patients to small amounts of the allergen that triggers their allergy symptoms, with the goal of building up their tolerance to the allergen over time. Allergy immunotherapy is used to treat a wide range of allergies and is typically administered in the form of injections, sublingual drops or tablets, or oral immunotherapy. It is a long-term treatment option that offers relief from allergy symptoms and can reduce the need for allergy medications.
Allergy Immunotherapy Epidemiology
The prevalence of allergies is increasing globally, leading to a rise in the demand for allergy immunotherapy. Allergies affect individuals of all ages and genders and can be triggered by a variety of environmental factors and lifestyle habits.
Based on prevalence, the allergy immunotherapy market is segmented into seasonal allergies, perennial allergies, food allergies, and others. Seasonal allergies are the most common type of allergy, with a high prevalence of allergic rhinitis and hay fever during the spring and fall months. Perennial allergies, such as allergies to pet dander and dust mites, are also prevalent throughout the year. Food allergies are another common type of allergy, affecting individuals of all ages and leading to potentially life-threatening reactions in some cases.
Based on age, the allergy immunotherapy market is divided into children and adults. Allergies can develop at any age, with many individuals experiencing their first allergy symptoms during childhood. Children are a significant market for allergy immunotherapy, as early intervention with immunotherapy can prevent the development of asthma in children with allergies.
Based on gender, the allergy immunotherapy market is segmented into male and female. Allergies affect individuals of all genders, with certain types of allergies, such as food allergies, being more prevalent in females.
Based on lifestyle habits, the allergy immunotherapy market is divided into urban and rural populations. Urban populations are more likely to experience allergies, with exposure to air pollution and other environmental factors contributing to the development of allergies.
In summary, the allergy immunotherapy market is segmented based on prevalence, age, gender, and lifestyle habits. Allergies affect individuals of all ages and genders, and can be triggered by a variety of environmental factors and lifestyle habits. The allergy immunotherapy market is expected to grow in response to the increasing prevalence of allergies and the growing demand for safe and effective allergy treatments.
The market for allergy immunotherapy is highly competitive, with many players offering a wide range of products to cater to the diverse needs of healthcare providers and patients. The market is segmented based on product type, allergy type, distribution channel, and geography.
Based on product type, the market is divided into subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT). SCIT is the largest segment of the market, with a high demand for allergy shots that are administered in a clinical setting. SLIT involves the use of allergy drops or tablets that are placed under the tongue and can be taken at home.
Based on allergy type, the market is divided into seasonal allergies, perennial allergies, and food allergies. Seasonal allergies are the largest segment of the market, driven by the high prevalence of allergic rhinitis and hay fever during the spring and fall months.
Based on distribution channel, the market is divided into hospitals, specialty clinics, and pharmacies. Specialty clinics are the largest distribution channel segment of the market, owing to the high demand for allergy immunotherapy and the specialized care required for this treatment.
The market for allergy immunotherapy is expected to continue to grow at a steady pace, driven by the increasing prevalence of allergies and the growing demand for safe and effective allergy treatments. Advances in technology and research are expected to lead to the development of new and innovative treatments, which may provide more effective treatment options for patients with allergies.
Overall, the market for allergy immunotherapy is expected to continue to grow, driven by the increasing demand for safe and effective allergy treatments. Advances in technology and research are expected to lead to the development of new and innovative treatments, which may provide more effective treatment options for patients with allergies.
Allergy Immunotherapy Market: Introduction
Allergy immunotherapy is a type of treatment that is used to reduce the symptoms associated with allergies. This treatment involves exposing patients to small amounts of the allergen that triggers their allergy symptoms, gradually increasing the dose over time to build up their tolerance to the allergen.Allergy immunotherapy is used to treat a wide range of allergies, including seasonal allergies, food allergies, and allergies to pet dander, dust mites, and insect venom. It is typically recommended for individuals who have moderate to severe allergy symptoms that are not effectively controlled with medications or avoidance of the allergen.
The benefits of allergy immunotherapy include long-term relief from allergy symptoms, a reduced need for allergy medications, and the potential to prevent the development of asthma in children with allergies.
Allergy immunotherapy is typically administered in the form of injections, sublingual drops or tablets, or oral immunotherapy. Immunotherapy injections involve injecting small amounts of the allergen under the skin, while sublingual drops or tablets are placed under the tongue. Oral immunotherapy involves ingesting small amounts of the allergen in gradually increasing doses.
Allergy immunotherapy is typically administered by an allergist or immunologist in a clinical setting. Patients undergoing immunotherapy require close monitoring for potential side effects, such as allergic reactions.
In summary, allergy immunotherapy is a type of treatment that is used to reduce the symptoms associated with allergies. It involves gradually exposing patients to small amounts of the allergen that triggers their allergy symptoms, with the goal of building up their tolerance to the allergen over time. Allergy immunotherapy is used to treat a wide range of allergies and is typically administered in the form of injections, sublingual drops or tablets, or oral immunotherapy. It is a long-term treatment option that offers relief from allergy symptoms and can reduce the need for allergy medications.
Allergy Immunotherapy Epidemiology
The prevalence of allergies is increasing globally, leading to a rise in the demand for allergy immunotherapy. Allergies affect individuals of all ages and genders and can be triggered by a variety of environmental factors and lifestyle habits.
Based on prevalence, the allergy immunotherapy market is segmented into seasonal allergies, perennial allergies, food allergies, and others. Seasonal allergies are the most common type of allergy, with a high prevalence of allergic rhinitis and hay fever during the spring and fall months. Perennial allergies, such as allergies to pet dander and dust mites, are also prevalent throughout the year. Food allergies are another common type of allergy, affecting individuals of all ages and leading to potentially life-threatening reactions in some cases.
Based on age, the allergy immunotherapy market is divided into children and adults. Allergies can develop at any age, with many individuals experiencing their first allergy symptoms during childhood. Children are a significant market for allergy immunotherapy, as early intervention with immunotherapy can prevent the development of asthma in children with allergies.
Based on gender, the allergy immunotherapy market is segmented into male and female. Allergies affect individuals of all genders, with certain types of allergies, such as food allergies, being more prevalent in females.
Based on lifestyle habits, the allergy immunotherapy market is divided into urban and rural populations. Urban populations are more likely to experience allergies, with exposure to air pollution and other environmental factors contributing to the development of allergies.
In summary, the allergy immunotherapy market is segmented based on prevalence, age, gender, and lifestyle habits. Allergies affect individuals of all ages and genders, and can be triggered by a variety of environmental factors and lifestyle habits. The allergy immunotherapy market is expected to grow in response to the increasing prevalence of allergies and the growing demand for safe and effective allergy treatments.
Allergy Immunotherapy Market Segmentations
The market can be categorised into treatment type, allergen type, treatment channel, distribution channel, region.Market Breakup by Treatment Type
- Subcutaneous Immunotherapy (SCIT)
- Specific Immunotherapy (SIT)
- Sublingual Immunotherapy (SLIT)
- Sublingual Drops
- Sublingual Tablets
Market Breakup by Allergen Type
- Pollen Allergies
- Grass Pollen
- Tree Pollen
- Weed Pollen
- Food Allergies
- Peanut Allergies
- Tree Nut Allergies
- Shellfish Allergies
- Fish Allergies
- Egg Allergies
- Milk Allergies
- Soy Allergies
- Wheat Allergies
- Others
- Dust Mite Allergies
- Mold Allergies
- Animal Dander Allergies
- Insect Venom Allergies
Market Breakup by Treatment Channel
- Public
- Private
Market Breakup by Distribution Channel
- Direct Tenders
- Retail Sales
- Others
Market Breakup by Region
North America
- United States of America
- Canada
Europe
- United Kingdom
- Germany
- France
- Italy
- Others
Asia Pacific
- China
- Japan
- India
- ASEAN
- Australia
- Others
Latin America
- Brazil
- Argentina
- Mexico
- Others
Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Nigeria
- South Africa
- Others
Allergy Immunotherapy Market Scenario
The global market for allergy immunotherapy is growing rapidly, driven by the increasing prevalence of allergies and the development of new and innovative treatments. Allergy immunotherapy is a long-term treatment option that offers relief from allergy symptoms and can reduce the need for allergy medications. It is typically recommended for individuals with moderate to severe allergy symptoms that are not effectively controlled with medications or avoidance of the allergen.The market for allergy immunotherapy is highly competitive, with many players offering a wide range of products to cater to the diverse needs of healthcare providers and patients. The market is segmented based on product type, allergy type, distribution channel, and geography.
Based on product type, the market is divided into subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT). SCIT is the largest segment of the market, with a high demand for allergy shots that are administered in a clinical setting. SLIT involves the use of allergy drops or tablets that are placed under the tongue and can be taken at home.
Based on allergy type, the market is divided into seasonal allergies, perennial allergies, and food allergies. Seasonal allergies are the largest segment of the market, driven by the high prevalence of allergic rhinitis and hay fever during the spring and fall months.
Based on distribution channel, the market is divided into hospitals, specialty clinics, and pharmacies. Specialty clinics are the largest distribution channel segment of the market, owing to the high demand for allergy immunotherapy and the specialized care required for this treatment.
The market for allergy immunotherapy is expected to continue to grow at a steady pace, driven by the increasing prevalence of allergies and the growing demand for safe and effective allergy treatments. Advances in technology and research are expected to lead to the development of new and innovative treatments, which may provide more effective treatment options for patients with allergies.
Overall, the market for allergy immunotherapy is expected to continue to grow, driven by the increasing demand for safe and effective allergy treatments. Advances in technology and research are expected to lead to the development of new and innovative treatments, which may provide more effective treatment options for patients with allergies.
Key Players in the Global Allergy Immunotherapy Market
The report gives an in-depth analysis of the key players involved in the allergy immunotherapy market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:- ALK-Abelló A/S
- Allergy Therapeutics
- Aimmune Therapeutics
- Stallergenes Greer
- Merck Group
- HAL Allergy Group
- DBV Technologies
- Biomay AG
- Anergis SA
- Circassia Pharmaceuticals
- Laboratorios LETI
- HollisterStier Allergy
Table of Contents
1 Preface
3 Allergy Diseases Overview
4 Patient Profile
5 Allergy Epidemiology Analysis
6 Global Allergy Immunotherapy Market Overview
7 Global Allergy Immunotherapy Market Landscape
8 Allergy Immunotherapy Challenges and Unmet Needs
10 Global Allergy Immunotherapy Market Dynamics
11 Global Allergy Immunotherapy Market Segmentation
12 North America Allergy Immunotherapy Market
13 Europe Allergy Immunotherapy Market
14 Asia Pacific Allergy Immunotherapy Market
15 Latin America Allergy Immunotherapy Market
16 Middle East and Africa Allergy Immunotherapy Market
17 Regulatory Framework
18 Patent Analysis
19 Grants Analysis
20 Clinical Trials Analysis
21 Funding and Investment Analysis
22 Partnership and Collaborations Analysis
23 Supplier Landscape
24 Allergy Immunotherapy Market- Distribution Model (Additional Insight)
26 Company Competitiveness Analysis (Additional Insight)
27 Payment Methods (Additional Insight)
Companies Mentioned
- Alk-Abelló A/S
- Allergy Therapeutics
- Aimmune Therapeutics
- Stallergenes Greer
- Merck Group
- Hal Allergy Group
- Dbv Technologies
- Biomay AG
- Anergis Sa
- Circassia Pharmaceuticals
- Laboratorios Leti
- Hollisterstier Allergy
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 147 |
| Published | April 2023 |
| Forecast Period | 2023 - 2031 |
| Estimated Market Value ( USD | $ 2.24 Billion |
| Forecasted Market Value ( USD | $ 4.67 Billion |
| Compound Annual Growth Rate | 9.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
